Health
BU researchers find how SARS-CoV-2 infection may drive deadly lung inflammation – News-Medical.Net
Responding to the COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2, requires models that can duplicate disease development in humans, identify potential targets and enable drug testing.
Reviewed by Emily Henderson, B.Sc.Sep 21 2020
Responding to the COVID-19 pandemic caused by the novel coronavirus, SARS-CoV-2, requires models that can duplicate disease development in humans, identify potential targets and enable drug testing. Specifically, access to primary human lung in vitro model systems is a priority since a variety of respiratory epithelial cells are the proposed targets of viral entry.
Now, a team of infectious disease, pulmonary and regenerative medicine researchers a…
-
Business20 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News23 hours agoDramatic details emerge of moment woman loses arm in attack by lion in Queensland Zoo
-
Noosa News20 hours agoQueensland’s nurses and midwives ramp up industrial action as pay negotiations break down
-
Noosa News20 hours agoQueensland racing, campdrafting events to continue after Hendra detection